Wellgistics Health (NASDAQ: WGRX) recently received a number of ratings updates from brokerages and research firms:
- 12/1/2025 – Wellgistics Health had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/25/2025 – Wellgistics Health had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/19/2025 – Wellgistics Health had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
- 11/13/2025 – Wellgistics Health had its “sell (e+)” rating reaffirmed by analysts at Weiss Ratings.
- 10/8/2025 – Wellgistics Health had its “sell (e)” rating reaffirmed by analysts at Weiss Ratings.
Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.
See Also
- Five stocks we like better than Wellgistics Health
- What is a Microcap Stock? Everything You Need to Know
- Checkmate in the Cloud: ServiceNow’s Shopping Spree
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- The Contrarian Case for MSTR Amid MSCI Delisting Debacle
- What is diluted earnings per share (Diluted EPS)?
- Worried About Mag 7 Concentration Risk? This ETF Could Help
Receive News & Ratings for Wellgistics Health Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health Inc and related companies with MarketBeat.com's FREE daily email newsletter.
-logo-1200x675.png?v=20230920074015&h=45&w=95&zc=2){kind=logo}
